SCHEMBL223566

SCHEMBL223566

COc1ccccc1OCc1c[nH]cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
SMN1; SMN2 Q16637 5/20 0.47
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
APP P05067 1/20 0.46
FFAR1 O14842 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
PKM P14618 2/20 0.43
MAPT P10636 2/20 0.43
MRGPRX4 Q96LA9 1/20 0.42
RXRA P19793 1/20 0.42
HTR1A P08908 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6358732 0.91 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2RAB9ANPC1APP
SCHEMBL226843 0.83 NISCH (0.48) ALDH1A1SMN1; SMN2RAB9ANPC1L3MBTL1
SCHEMBL224554 0.83 LTA4H (0.50) L3MBTL1TDP1MAPTHTR1AADRA1D
SCHEMBL224978 0.83 NISCH (0.51) ALDH1A1SMN1; SMN2TDP1MAPTHTR1A
SCHEMBL222619 0.81 NISCH (0.50) L3MBTL1MAPTHTR1AMEN1KMT2A
SCHEMBL224611 0.80 TP53 (0.45) ALDH1A1SMN1; SMN2RAB9ANPC1FFAR1
SCHEMBL224997 0.80 GAA (0.47) ALDH1A1SMN1; SMN2APPCA1CA2
SCHEMBL224876 0.80 MEN1 (0.44) ALDH1A1FFAR1L3MBTL1TDP1MRGPRX4
SCHEMBL31531665 0.80 SYK (0.43) ALDH1A1TDP1MEN1KMT2ASYK
SCHEMBL223663 0.80 RXRA (0.46) ALDH1A1RXRAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004230-A1 IMIDAZOLE DERIVATIVES GALLEY GUIDO (DE) 2012-01-05 US claimed
US-20100204233-A1 IMIDAZOLE DERIVATIVES GALLEY GUIDO 2010-08-12 US claimed
US-20080146523-A1 IMIDAZOLE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-06-19 US claimed
US-8399463-B2 Imidazole derivatives HOFFMANN-LA ROCHE INC. (US) 2013-03-19 US disclosed
US-20120004230-A1 IMIDAZOLE DERIVATIVES GALLEY GUIDO (DE) 2012-01-05 US disclosed
US-20100204233-A1 IMIDAZOLE DERIVATIVES GALLEY GUIDO 2010-08-12 US disclosed
EP-2094668-A2 4-IMIDAZOLINES AS TAAR'S LIGANDS F. Hoffmann-Roche AG (CH) 2009-09-02 EP disclosed
WO-2008074679-A2 4-IMIDAZOLINES AS TAAR'S LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2008-06-26 WO disclosed
US-20080146523-A1 IMIDAZOLE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204233-A1 IMIDAZOLE DERIVATIVES TAAR1, TAAR5, TACR1 ALDH1A1 246/4885SMN1; SMN2 4392/4885RAB9A 2197/4885
US-20120004230-A1 IMIDAZOLE DERIVATIVES TAAR1, TAAR5, TACR1 ALDH1A1 246/4885SMN1; SMN2 4392/4885RAB9A 2197/4885
US-20080146523-A1 IMIDAZOLE DERIVATIVES TAAR1, TAAR5, TACR1 ALDH1A1 246/4885SMN1; SMN2 4392/4885RAB9A 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.